GLP-1R agonists represents a novel class of anti-hyperglycemic agent that improve health and survival of -cells (improvement in postprandial hyperglycemia), suppress glucagon (improvement in fasting hyperglycemia), improve insulin resistance (modest effect) and influence energy intake (augment satiety signal) with minimal, if at all, any side effects (weight neutral and non-hypoglycemic)
Whether you are just starting to research GLP-1 medications or you are already looking for ways to manage side effects, a personalized program is the most reliable way to achieve sustainable results
Consult a Healthcare Provider Before starting semaglutide, orlistat, or both medications together, it is essential to consult a doctor
Eligibility Are You Suitable
7 Faculty of Life and Health Sciences, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
Listen to your body and adjust intensity as needed